Finance

Lists
Why is MDMA down 13,89%?
Dive Deeper
MDMA:CNSX
Pharmala Biotech Holdings Inc
0,16 CA$
-13,89%
(-0,025) 1D
16 հոկ, 16:00:00 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for MDMA...
Open
0,19 CA$
High
0,19 CA$
Low
0,16 CA$
Mkt. cap
16,83 մլն
Avg. vol.
170,65 հզր
Volume
384,01 հզր
52-wk high
0,33 CA$
52-wk low
0,08 CA$
EPS
-0,02 CA$
No. of employees
3
Open
0,19 CA$
High
0,19 CA$
Low
0,16 CA$
Mkt. cap
16,83 մլն
Avg. vol.
170,65 հզր
Volume
384,01 հզր
52-wk high
0,33 CA$
52-wk low
0,08 CA$
EPS
-0,02 CA$
No. of employees
3
News stories
From web sources and news partners
About Pharmala Biotech Holdings Inc
CEO-
Employees3
Founded2021
HeadquartersՏորոնտո, Օնտարիո, Կանադա
Sector-
Last report
29 հլս, 2026 թ.
Fiscal period
Q3 2026
- / -
Revenue / Est. (CAD)
513,23 հզր / -
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
2025 թ. օգս
2025 թ. նոյ
2026 թ. փտվ
2026 թ. մյս
Revenue
267,38 հզր
206,44 հզր
280,58 հզր
513,23 հզր
Cost of goods sold
34,04 հզր
34,84 հզր
22,41 հզր
174,69 հզր
Cost of revenue
34,04 հզր
34,84 հզր
22,41 հզր
174,69 հզր
Research and development expenses
44,91 հզր
41,10 հզր
40,53 հզր
44,91 հզր
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
404,68 հզր
320,96 հզր
367,29 հզր
472,32 հզր
Operating expense
553,47 հզր
498,41 հզր
559,82 հզր
810,59 հզր
Total operating expenses
587,50 հզր
533,25 հզր
582,22 հզր
985,28 հզր
Operating income
-320,13 հզր
-326,81 հզր
-301,64 հզր
-472,05 հզր
Other non operating income
-41,00 հզր
-16,84 հզր
-46,18 հզր
-40,97 հզր
EBT including unusual items
-361,13 հզր
-409,70 հզր
-337,70 հզր
-499,76 հզր
EBT excluding unusual items
-361,13 հզր
-343,65 հզր
-347,82 հզր
-513,01 հզր
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-361,13 հզր
-409,70 հզր
-337,70 հզր
-499,76 հզր
Net profit margin
-135,07%
-198,46%
-120,35%
-97,37%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
29,19 հզր
29,76 հզր
29,74 հզր
30,02 հզր
EBITDA
-306,98 հզր
-313,10 հզր
-287,95 հզր
-458,08 հզր
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps